Verition Fund Management’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-10,673
| Closed | -$31.2K | – | 2838 |
|
|
2024
Q2 | $31.2K | Buy |
+10,673
| New | +$31.2K | ﹤0.01% | 2186 |
|
|
2023
Q2 | – | Sell |
-47,579
| Closed | -$147K | – | 2317 |
|
|
2023
Q1 | $147K | Buy |
47,579
+34,079
| +252% | +$105K | ﹤0.01% | 1679 |
|
|
2022
Q4 | $71.6K | Buy |
+13,500
| New | +$71.6K | ﹤0.01% | 1461 |
|